Respiratory News and Research

RSS

Cambridge scientists successfully create 'mini-lungs' to study cystic fibrosis

Scientists at the University of Cambridge have successfully created 'mini-lungs' using stem cells derived from skin cells of patients with cystic fibrosis, and have shown that these can be used to test potential new drugs for this debilitating lung disease.

20 Mar 2015

Survey: Number of UK adults living with cystic fibrosis expected to increase by 2025

The number of people living with cystic fibrosis into adulthood in the UK is expected to increase dramatically - by as much as 80 per cent - by 2025, according to a Europe-wide survey, the UK end of which was led by Queen's University Belfast.

20 Mar 2015

AIR Louisville to use digital health technology to improve asthma

Today marks the start of AIR Louisville, the first-of-its-kind data-driven collaboration among public, private and philanthropic organizations to use digital health technology to improve asthma. Kentucky has the fourth highest adult asthma prevalence in the US and Louisville consistently ranks among the top 20 "most challenging" cities to live in with asthma.

20 Mar 2015

New pre-clinical, clinical data for IMBRUVICA to be highlighted at AACR Annual Meeting

Pharmacyclics, Inc. today announced that new pre-clinical and clinical data for ibrutinib (IMBRUVICA) will be highlighted at the 2015 American Association for Cancer Research Annual Meeting to be held April 18 – 22, 2015, in Philadelphia, PA.

19 Mar 2015

MSU researchers discover cause of death in children who get malaria

Researchers from Michigan State University have uncovered the cause of death in children who die from cerebral malaria.

19 Mar 2015

Daiichi Sankyo signs co-commercialization agreement with AstraZeneca for MOVANTIK (naloxegol)

Daiichi Sankyo, Inc. today announced a co-commercialization agreement with AstraZeneca for MOVANTIK (naloxegol) in the US, in line with the Daiichi Sankyo strategy to expand its US portfolio through strategic alliances, in addition to internal R&D and acquisitions.

19 Mar 2015

Oxygen wristbands: an interview with Dr Gillian Lowrey

Oxygen is delivered with variable flows that administer different concentrations. National guidelines were published in 2009 that provide recommendations about prescribing the oxygen and titrating it to certain target ranges.

18 Mar 2015

BD announces completion of CareFusion acquisition

Becton, Dickinson and Company today announced that it completed its acquisition of CareFusion Corporation pursuant to the terms of its previously announced Agreement and Plan of Merger, dated October 5, 2014 (the "Merger Agreement").

From BD (Becton, Dickinson and Company) 17 Mar 2015

Researchers identify new gene variants that could contribute to sporadic motor neurone disease

Researchers have identified a new host of gene variants that could make people vulnerable to sporadic motor neurone disease, according to a report published today in the journal, Scientific Reports.

17 Mar 2015

Endo announces commercial availability of NATESTO nasal gel for men with hypogonadism

Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (NASDAQ: ENDP) (TSX: ENL), announced today the commercial availability of NATESTO (testosterone nasal gel), the first and only nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism.

16 Mar 2015

Egalet announces net revenues of $1.9 million for 2014

Egalet Corporation today reported financial results for the year ended December 31, 2014.

16 Mar 2015

Ruthigen, Pulmatrix sign definitive merger agreement

Ruthigen, Inc., a biopharmaceutical company, and Pulmatrix, Inc., a Lexington, Massachusetts based clinical stage biotechnology company, announced today that on March 13, 2015, they have entered into a definitive merger agreement.

16 Mar 2015

Meta-analysis finds that high dose zinc acetate lozenges may help reduce duration of cold symptoms

According to a meta-analysis published in BMC Family Practice, high dose zinc acetate lozenges shortened the duration of common-cold associated nasal discharge by 34%, nasal congestion by 37%, scratchy throat by 33%, and cough by 46%.

16 Mar 2015

Exposure to diesel exhaust may exacerbate respiratory diseases

Researchers in the UK have, for the first time, shown how exhaust pollution from diesel engines is able to affect nerves within the lung. Air pollution is a significant threat to health, they say, and identifying potential mechanisms linking exposure to diesel exhaust and the exacerbation of respiratory diseases may lead to treatments for those affected.

16 Mar 2015

Antibiotic nanoparticles can help treat lung infection, prevent drug resistance

Treating respiratory disease is often difficult because drugs have to cross biological barriers such as respiratory tissue and mucosa, and must therefore be given in large quantities in order for an effective amount to reach the target.

13 Mar 2015

Gottlieb Allergy Count kicks off its first report of 2015

Those in the Midwest with sensitive respiratory systems will find relief beginning Monday, March 16 as the Gottlieb Allergy Count kicks off its first report of 2015. The Gottlieb Allergy Count is the official daily allergy count for the Midwest.

13 Mar 2015

TRMC expands use of capnography to monitor patients during moderate sedation

Tillamook Regional Medical Center recently strengthened patient safety measures by expanding its use of capnography to monitor patients during moderate sedation. Sedation is commonly used during procedures such as colonoscopies and in some instances can suppress breathing.

12 Mar 2015

More research needed to explore toxicity of cellulose nanocrystals, says Virginia Tech scientist

Are cellulose nanocrystals harmful to human health? The answer might depend on the route of exposure, according to a review of the literature by a Virginia Tech scientist, but there have been few studies and many questions remain.

12 Mar 2015

Early mobility therapy improves outcomes of patients with acute respiratory distress syndrome

Acute respiratory distress syndrome (ARDS) is a life-threatening lung condition that affects approximately 200,000 people a year in the United States and has a higher mortality rate than breast and prostate cancer combined. The condition most often occurs in people who are critically ill or who have significant injuries; those who do survive it often experience profound skeletal muscle weakness.

12 Mar 2015

Repeatedly exposing children to secondhand smoke is child abuse, argues Adam Goldstein

Purposefully and repeatedly exposing children to secondhand smoke — a known human carcinogen — is child abuse, according to an opinion piece written by Adam Goldstein, MD, MPH, a professor in the Department of Family Medicine at the University of North Carolina School of Medicine.

11 Mar 2015

Respiratory News and Research

Cambridge scientists successfully create 'mini-lungs' to study cystic fibrosis

Survey: Number of UK adults living with cystic fibrosis expected to increase by 2025

AIR Louisville to use digital health technology to improve asthma

New pre-clinical, clinical data for IMBRUVICA to be highlighted at AACR Annual Meeting

MSU researchers discover cause of death in children who get malaria

Daiichi Sankyo signs co-commercialization agreement with AstraZeneca for MOVANTIK (naloxegol)

Oxygen wristbands: an interview with Dr Gillian Lowrey

BD announces completion of CareFusion acquisition

Researchers identify new gene variants that could contribute to sporadic motor neurone disease

Endo announces commercial availability of NATESTO nasal gel for men with hypogonadism

Egalet announces net revenues of $1.9 million for 2014

Ruthigen, Pulmatrix sign definitive merger agreement

Meta-analysis finds that high dose zinc acetate lozenges may help reduce duration of cold symptoms

Exposure to diesel exhaust may exacerbate respiratory diseases

Antibiotic nanoparticles can help treat lung infection, prevent drug resistance

Gottlieb Allergy Count kicks off its first report of 2015

TRMC expands use of capnography to monitor patients during moderate sedation

More research needed to explore toxicity of cellulose nanocrystals, says Virginia Tech scientist

Early mobility therapy improves outcomes of patients with acute respiratory distress syndrome

Repeatedly exposing children to secondhand smoke is child abuse, argues Adam Goldstein

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News